Homburger advises OPAP on its business combination with Allwyn
On October 13, 2025, Allwyn International AG and OPAP S.A. announced that their respective boards of directors have approved the business combination of Allwyn and OPAP through an all-share transaction that values the resulting entity at an equity value of EUR 16 bn.
Homburger advised Idorsia Ltd on a placement of 16.4 m shares through an accelerated bookbuilding process, raising gross proceeds of CHF 65.6 m
On October 10, 2025, SIX-listed Idorsia Ltd announced the launch of an accelerated bookbuilding offering, which led to the successful placement of 16.4 m shares at an offer price of CHF 4.00 per offered share, raising aggregate gross proceeds of approximately CHF 65.6 m.
Homburger advised Danaher on the issuance of five tranches of CHF bonds in an aggregate principal amount of CHF 1.25 bn
On October 10, 2025, Danaher successfully completed its issuance of five tranches of CHF bonds in an aggregate principal amount of CHF 1.25 bn, consisting of (i) CHF 250 m in aggregate principal amount of 0.4773% Guaranteed Bonds due April 9, 2027,
Homburger advised UBS Group AG on its issuance of AUD 1.25 bn Tier 1 Capital Notes with an equity conversion feature
On September 29, 2025, UBS Group AG successfully completed its offering of AUD 1.25 bn in aggregate principal amount of 6.375 per cent. Tier 1 Capital Notes.
Homburger advises Landis+Gyr on the divestment of its EMEA business to AURELIUS
On September 29, 2025, Landis+Gyr Group AG, a leading global provider of integrated energy management solutions, announced that it has entered into a share purchase agreement to divest its operations in the Europe, Middle East and Africa (EMEA) region to AURELIUS, a global private equity investor, for an enterprise value of USD 215 m.
Homburger advised 21Shares on the listing of three new series of crypto-linked exchange traded products as well as cross-listing of three existing series of crypto-linked exchange traded products on SIX Swiss Exchange
On August 29, 2025, September 17, 2025 and September 30, 2025, respectively, 21Shares AG, a leading global issuer of crypto exchange traded products (ETPs), successfully issued and listed three new series of crypto-linked ETPs on the SIX Swiss Exchange. The first series, 21Shares Hyperliquid ETP (HYPE), has Hyperliquid (HYPE) as underlying, the native token of …
Homburger advised Luzerner Kantonalbank AG on the issuance of its CHF 200 m 1.400% Tier 2 Bonds
On September 17, 2025, Luzerner Kantonalbank AG issued CHF 200 m 1.400% Tier 2 Bonds.
Homburger advised Santhera in connection with its CHF 20 m Royalty Monetization and Convertible Bond Financing
On September 23, 2025, Santhera Pharmaceuticals Holding AG (SIX: SANN) announced that it had secured an USD 13 m royalty monetization financing with R-Bridge, an affiliate of CBC Group, Asia’s largest healthcare-focused investment firm. Santhera is monetizing 25% of net royalties on its product AGAMREE®.
Homburger advised UBS Group AG on its issuance of USD 5 bn Fixed Rate/Floating Rate Callable Senior Notes and Floating Rate Callable Senior Notes under its Senior Debt Programme
On September 23, 2025, UBS Group AG successfully completed its issuance of (i) USD 1.25 bn Fixed Rate/Floating Rate Callable Senior Notes due December 2029,
Homburger advised Madrigal in connection with its new USD 500 m financing
On July 17, 2025, Madrigal Pharmaceuticals, Inc., a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need, secured a USD 500 m senior secured credit facility from Blue Owl Capital to advance its pharmaceutical pipeline.